Key facts
- This page summarizes Garry A. Nicholson's Form 4 filing for NextCure, Inc. (NXTC).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Jun 2023, 16:31.
Garry A. Nicholson - 22 Jun 2023 Form 4 Insider Report for NextCure, Inc. (NXTC)
- Reporting relationship
- Director
- Issuer ticker
- NXTC
- Reported as of
- 22 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jun 2023, 16:31:09 UTC
- Prior SEC filing
- 16 Jun 2023
- Next SEC filing
- 28 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Steven P. Cobourn, as attorney-in fact for Garry A. Nicholson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Garry A. Nicholson filed Form 4 for NextCure, Inc. (NXTC) on 23 Jun 2023.
Change
- Previous filing in this sequence was filed on 16 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NXTC
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +14,250
- Change %
- Price
- $0.000000
- Shares after
- 14,250
- Date
- 22 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,250
- Exercise price
- $1.62
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders.